Michael O’Dwyer
Company: ONK Therapeutics
Job title: Chief Scientific Officer
Seminars:
Harnessing CRISPR to Knock Out Checkpoint Inhibitors to Enhance CAR-NK Function 11:30 am
day: Focus Day Track 2
September 19-23, 2022
Boston, MA